NCT05405413View on ClinicalTrials.gov

CAncer TReatment INformed by the Molecular Tumor Board At Dartmouth

PHASE2RecruitingINTERVENTIONAL
Enrollment

192

Participants

Timeline

Start Date

March 19, 2024

Primary Completion Date

May 31, 2029

Study Completion Date

December 31, 2029

Conditions
Cancer
Interventions
OTHER

Treatment recommendations made by Molecular Tumor Board.

"Molecular Tumor Board recommendations may include any of the following:~(A) a tumor-targeted drug (alone or in combination)~(B) an antibody-based immunotherapy (alone or in combination)~(C) neither (A) nor (B).~(D) referral to the Familial Cancer Program~(E) referral for germline genetic testing"

Trial Locations (1)

03756

RECRUITING

Dartmouth-Hitchcock Medical Center, Lebanon

All Listed Sponsors
lead

Dartmouth-Hitchcock Medical Center

OTHER